Alemtuzumab

Details

Files
Generic Name:
Alemtuzumab
Project Status:
Withdrawn
Therapeutic Area:
Multiple sclerosis, relapsing-remitting
Manufacturer:
Genzyme Canada, a Division of sanofi-aventis Canada Inc.
Call for patient/clinician input open:
Brand Name:
Lemtrada
Project Line:
Reimbursement Review
Project Number:
SR0355-000
Call for patient/clinician input closed:
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Multiple Sclerosis, relapsing